[
  {
    "ts": null,
    "headline": "ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons",
    "summary": "AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this population lacking.",
    "url": "https://finnhub.io/api/news?id=4f49a948c6a65a15f018bed6eaa5d09296d55e005bc94144a692ae2a91f26406",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748966986,
      "headline": "ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons",
      "id": 134981598,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this population lacking.",
      "url": "https://finnhub.io/api/news?id=4f49a948c6a65a15f018bed6eaa5d09296d55e005bc94144a692ae2a91f26406"
    }
  },
  {
    "ts": null,
    "headline": "Bert's May 2025 Dividend Income Summary",
    "summary": "May was a strange month for dividend income. Click to read.",
    "url": "https://finnhub.io/api/news?id=5b48cec3baf8997dfb8483f8112b6c82e497d0280ed14153ba0cb4b17d652102",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748958180,
      "headline": "Bert's May 2025 Dividend Income Summary",
      "id": 134981961,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155849478/image_2155849478.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "May was a strange month for dividend income. Click to read.",
      "url": "https://finnhub.io/api/news?id=5b48cec3baf8997dfb8483f8112b6c82e497d0280ed14153ba0cb4b17d652102"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals",
    "summary": "AbbVie (NYSE: ABBV) today announced the second annual AbbVie Migraine Career Catalyst Award™ contest is now accepting entries. AbbVie is proud to continue this nationwide initiative supporting people living with migraine by awarding 20 entrants with $2,500 each that they may use to pursue their personal, professional, and educational goals.",
    "url": "https://finnhub.io/api/news?id=e4dd3251a110be7c86e1c858564202d062b652f130020284a478013951bb3df7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748952900,
      "headline": "AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals",
      "id": 134978837,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) today announced the second annual AbbVie Migraine Career Catalyst Award™ contest is now accepting entries. AbbVie is proud to continue this nationwide initiative supporting people living with migraine by awarding 20 entrants with $2,500 each that they may use to pursue their personal, professional, and educational goals.",
      "url": "https://finnhub.io/api/news?id=e4dd3251a110be7c86e1c858564202d062b652f130020284a478013951bb3df7"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference",
    "summary": "AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025. Management will participate in a fireside chat at 10:20 a.m. Central time.",
    "url": "https://finnhub.io/api/news?id=af0e33d8632d70c3430b8bfc03512435258219c6476f6c5afc7d4b4b75cd4e36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748952000,
      "headline": "AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference",
      "id": 134978838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025. Management will participate in a fireside chat at 10:20 a.m. Central time.",
      "url": "https://finnhub.io/api/news?id=af0e33d8632d70c3430b8bfc03512435258219c6476f6c5afc7d4b4b75cd4e36"
    }
  },
  {
    "ts": null,
    "headline": "High Growth Tech Stocks To Watch In The US June 2025",
    "summary": "Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.",
    "url": "https://finnhub.io/api/news?id=82bcdbf57ae2a687b1d5d07c96f559e83b56e4049047b640f3c21f43ffba5fa3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748950694,
      "headline": "High Growth Tech Stocks To Watch In The US June 2025",
      "id": 134976251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.",
      "url": "https://finnhub.io/api/news?id=82bcdbf57ae2a687b1d5d07c96f559e83b56e4049047b640f3c21f43ffba5fa3"
    }
  },
  {
    "ts": null,
    "headline": "abrdn World Healthcare Fund Q1 2025 Commentary",
    "summary": "The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.",
    "url": "https://finnhub.io/api/news?id=38a3fa6a8cead9c9e75f77bfc020116de74993e8dc05a0e0b75137cad50c9df0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748938800,
      "headline": "abrdn World Healthcare Fund Q1 2025 Commentary",
      "id": 134976414,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/91598774/image_91598774.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.",
      "url": "https://finnhub.io/api/news?id=38a3fa6a8cead9c9e75f77bfc020116de74993e8dc05a0e0b75137cad50c9df0"
    }
  }
]